These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 12482415)

  • 1. Small, low nanomolar, noncovalent thrombin inhibitors lacking a group to fill the 'distal binding pocket'.
    Sanderson PE; Cutrona KJ; Dyer DL; Krueger JA; Kuo LC; Lewis SD; Lucas BJ; Yan Y
    Bioorg Med Chem Lett; 2003 Jan; 13(2):161-4. PubMed ID: 12482415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. From natural products to achiral drug prototypes: potent thrombin inhibitors based on P2/P3 dihydropyrid-2-one core motifs.
    Hanessian S; Therrien E; Zhang J; Otterlo Wv; Xue Y; Gustafsson D; Nilsson I; Fjellström O
    Bioorg Med Chem Lett; 2009 Sep; 19(18):5429-32. PubMed ID: 19674897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective 3-amino-2-pyridinone acetamide thrombin inhibitors incorporating weakly basic partially saturated heterobicyclic P1-arginine mimetics.
    Peterlin-Masic L; Kranjc A; Marinko P; Mlinsek G; Solmajer T; Stegnar M; Kikelj D
    Bioorg Med Chem Lett; 2003 Oct; 13(19):3171-6. PubMed ID: 12951087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 2-(2-Chloro-6-fluorophenyl)acetamides as potent thrombin inhibitors.
    Lee L; Kreutter KD; Pan W; Crysler C; Spurlino J; Player MR; Tomczuk B; Lu T
    Bioorg Med Chem Lett; 2007 Nov; 17(22):6266-9. PubMed ID: 17889527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis and biological evaluation of thrombin inhibitors based on a pyridine scaffold.
    Blomberg D; Fex T; Xue Y; Brickmann K; Kihlberg J
    Org Biomol Chem; 2007 Aug; 5(16):2599-605. PubMed ID: 18019535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis, and thrombin-inhibitory activity of pyridin-2-ones as P2/P3 core motifs.
    Hanessian S; Simard D; Bayrakdarian M; Therrien E; Nilsson I; Fjellström O
    Bioorg Med Chem Lett; 2008 Mar; 18(6):1972-6. PubMed ID: 18289852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolism-directed optimization of 3-aminopyrazinone acetamide thrombin inhibitors. Development of an orally bioavailable series containing P1 and P3 pyridines.
    Burgey CS; Robinson KA; Lyle TA; Sanderson PE; Lewis SD; Lucas BJ; Krueger JA; Singh R; Miller-Stein C; White RB; Wong B; Lyle EA; Williams PD; Coburn CA; Dorsey BD; Barrow JC; Stranieri MT; Holahan MA; Sitko GR; Cook JJ; McMasters DR; McDonough CM; Sanders WM; Wallace AA; Clayton FC; Bohn D; Leonard YM; Detwiler TJ; Lynch JJ; Yan Y; Chen Z; Kuo L; Gardell SJ; Shafer JA; Vacca JP
    J Med Chem; 2003 Feb; 46(4):461-73. PubMed ID: 12570369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and structure-activity relationships of substituted pyridones as inhibitors of Pim-1 kinase.
    Cheney IW; Yan S; Appleby T; Walker H; Vo T; Yao N; Hamatake R; Hong Z; Wu JZ
    Bioorg Med Chem Lett; 2007 Mar; 17(6):1679-83. PubMed ID: 17251021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic optimization of 3-amino-6-chloropyrazinone acetamide thrombin inhibitors. Implementation of P3 pyridine N-oxides to deliver an orally bioavailable series containing P1 N-benzylamides.
    Burgey CS; Robinson KA; Lyle TA; Nantermet PG; Selnick HG; Isaacs RC; Lewis SD; Lucas BJ; Krueger JA; Singh R; Miller-Stein C; White RB; Wong B; Lyle EA; Stranieri MT; Cook JJ; McMasters DR; Pellicore JM; Pal S; Wallace AA; Clayton FC; Bohn D; Welsh DC; Lynch JJ; Yan Y; Chen Z; Kuo L; Gardell SJ; Shafer JA; Vacca JP
    Bioorg Med Chem Lett; 2003 Apr; 13(7):1353-7. PubMed ID: 12657281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In-depth study of tripeptide-based alpha-ketoheterocycles as inhibitors of thrombin. Effective utilization of the S1' subsite and its implications to structure-based drug design.
    Costanzo MJ; Almond HR; Hecker LR; Schott MR; Yabut SC; Zhang HC; Andrade-Gordon P; Corcoran TW; Giardino EC; Kauffman JA; Lewis JM; de Garavilla L; Haertlein BJ; Maryanoff BE
    J Med Chem; 2005 Mar; 48(6):1984-2008. PubMed ID: 15771442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 3-amino-4-sulfonylpyridinone acetamide and related pyridothiadiazine thrombin inhibitors.
    Sanderson PE; Cutrona KJ; Savage KL; Naylor-Olsen AM; Bickel DJ; Bohn DL; Clayton FC; Krueger JA; Lewis SD; Lucas BJ; Lyle EA; Wallace AA; Welsh DC; Yan Y
    Bioorg Med Chem Lett; 2003 Apr; 13(8):1441-4. PubMed ID: 12668008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacious, orally bioavailable thrombin inhibitors based on 3-aminopyridinone or 3-aminopyrazinone acetamide peptidomimetic templates.
    Sanderson PE; Lyle TA; Cutrona KJ; Dyer DL; Dorsey BD; McDonough CM; Naylor-Olsen AM; Chen IW; Chen Z; Cook JJ; Cooper CM; Gardell SJ; Hare TR; Krueger JA; Lewis SD; Lin JH; Lucas BJ; Lyle EA; Lynch JJ; Stranieri MT; Vastag K; Yan Y; Shafer JA; Vacca JP
    J Med Chem; 1998 Nov; 41(23):4466-74. PubMed ID: 9804686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel morpholinone-based D-Phe-Pro-Arg mimics as potential thrombin inhibitors: design, synthesis, and X-ray crystal structure of an enzyme inhibitor complex.
    Dahlgren A; Johansson PO; Kvarnström I; Musil D; Nilsson I; Samuelsson B
    Bioorg Med Chem; 2002 Jun; 10(6):1829-39. PubMed ID: 11937341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and synthesis of a series of potent and orally bioavailable noncovalent thrombin inhibitors that utilize nonbasic groups in the P1 position.
    Tucker TJ; Brady SF; Lumma WC; Lewis SD; Gardell SJ; Naylor-Olsen AM; Yan Y; Sisko JT; Stauffer KJ; Lucas BJ; Lynch JJ; Cook JJ; Stranieri MT; Holahan MA; Lyle EA; Baskin EP; Chen IW; Dancheck KB; Krueger JA; Cooper CM; Vacca JP
    J Med Chem; 1998 Aug; 41(17):3210-9. PubMed ID: 9703466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel non-covalent thrombin inhibitors incorporating P(1) 4,5,6,7-tetrahydrobenzothiazole arginine side chain mimetics.
    Marinko P; Krbavcic A; Mlinsek G; Solmajer T; Bakija AT; Stegnar M; Stojan J; Kikelj D
    Eur J Med Chem; 2004 Mar; 39(3):257-65. PubMed ID: 15051174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 2-Oxo-1,2-dihydropyridinyl-3-yl amide-based GPa inhibitors: Design, synthesis and structure-activity relationship study.
    Loughlin WA; Jenkins ID; Karis ND; Schweiker SS; Healy PC
    Eur J Med Chem; 2016 Mar; 111():1-14. PubMed ID: 26851835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The crystal structures of human alpha-thrombin complexed with active site-directed diamino benzo[b]thiophene derivatives: a binding mode for a structurally novel class of inhibitors.
    Chirgadze NY; Sall DJ; Briggs SL; Clawson DK; Zhang M; Smith GF; Schevitz RW
    Protein Sci; 2000 Jan; 9(1):29-36. PubMed ID: 10739244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of potent, selective 4-fluoroproline-based thrombin inhibitors with improved metabolic stability.
    Staas DD; Savage KL; Sherman VL; Shimp HL; Lyle TA; Tran LO; Wiscount CM; McMasters DR; Sanderson PE; Williams PD; Lucas BJ; Krueger JA; Lewis SD; White RB; Yu S; Wong BK; Kochansky CJ; Anari MR; Yan Y; Vacca JP
    Bioorg Med Chem; 2006 Oct; 14(20):6900-16. PubMed ID: 16870455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure of thrombin complexed with selective non-electrophilic inhibitors having cyclohexyl moieties at P1.
    Krishnan R; Mochalkin I; Arni R; Tulinsky A
    Acta Crystallogr D Biol Crystallogr; 2000 Mar; 56(Pt 3):294-303. PubMed ID: 10713516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. L-374,087, an efficacious, orally bioavailable, pyridinone acetamide thrombin inhibitor.
    Sanderson PE; Cutrona KJ; Dorsey BD; Dyer DL; McDonough CM; Naylor-Olsen AM; Chen IW; Chen Z; Cook JJ; Gardell SJ; Krueger JA; Lewis SD; Lin JH; Lucas BJ; Lyle EA; Lynch JJ; Stranieri MT; Vastag K; Shafer JA; Vacca JP
    Bioorg Med Chem Lett; 1998 Apr; 8(7):817-22. PubMed ID: 9871547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.